All News about Hutchmed China Ltd ADR![]() ![]() ![]() ![]() ![]() ![]() ![]()
HUTCHMED Out Licenses Fruquintinib To Takeda Outside China
January 23, 2023
Via Benzinga
![]()
Hutchmed Plans Strategic Focus Shift On Late-Stage Programs, Details Not Disclosed
November 15, 2022
Via Benzinga
![]() ![]()
HUTCHMED Confirms No Assets Held at Silicon Valley Bank
March 12, 2023
Via GlobeNewswire
![]() ![]()
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 08, 2023
Via Benzinga
![]()
HUTCHMED Reports 2022 Full Year Results and Provides Business Updates
February 28, 2023
Via GlobeNewswire
![]() ![]() ![]() ![]()
HUTCHMED to Announce 2022 Final Results
January 31, 2023
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|